Health CarePharmaceuticals & Biotechnology
  • Price (HKD)5.01
  • Today's Change0.00 / 0.00%
  • Shares traded22.63m
  • 1 Year change-13.82%
  • Beta0.2126
Data delayed at least 15 minutes, as of Aug 30 2016 08:04 BST.
More ▼

Events & Activity

  • 1177:HKG reported earnings of 0.070 for the period of the year 2016Q2.

Key statistics

As of last trade Sino Biopharmaceutical Ltd (1177:HKG) traded at 5.01, 8.68% above its 52-week low of 4.61, set on May 23, 2016.
52-week range
Today
4.61May 23 20167.77Dec 04 2015
Markit short selling activity
Low
Med
High
Open5.00
High5.05
Low5.00
Bid5.01
Offer5.02
Previous close5.01
Average volume19.09m
Shares outstanding7.41bn
Free float4.26bn
P/E (TTM)19.88
Market cap38.77bn HKD
EPS (TTM)0.263 HKD
Annual div (IAD)0.055 HKD
Annual div yield (IAD)1.05%
Div ex-dateJun 28 2016
Div pay-dateJul 13 2016
Next div ex-dateSep 12 2016
Next div pay-dateSep 29 2016
Data delayed at least 15 minutes, as of Aug 30 2016 08:04 BST.
More ▼
© Thomson Reuters Click for restrictions
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.